Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report sent to investors on Monday. The brokerage issued a buy rating on the health services provider’s stock. A number of other research analysts have also commented on the company. Truist Financial upped their price target on Amedisys from $97.00 to […]
Paralel Advisors LLC lifted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 2.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,499 shares of the health services provider’s stock after purchasing an additional 276 shares during the period. […]
Paralel Advisors LLC boosted its stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 2.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,499 shares of the health services provider’s stock after acquiring an additional 276 shares during the period. […]
StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a report issued on Sunday. The firm issued a buy rating on the health services provider’s stock. Other equities research analysts also recently issued research reports about the stock. SVB Securities reduced their price objective on shares of Amedisys from $96.00 to $81.00 […]
Principal Financial Group Inc. grew its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 0.5% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 326,134 shares of the health services provider’s stock after acquiring an additional 1,761 shares during the period. Principal Financial Group […]